Iambic Therapeutics said on Monday early-stage data of its experimental drug showed anti-tumor activity in heavily pretreated cancer patients with mutations in the HER2 gene.

More and more foreign businesses are looking at the Lehigh Valley to expand, and that's giving the region a new kind of international attention. The latest is French newspaper Le Monde, which ...

BLENREP is indicated in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of ...